Sort by
Refine Your Search
-
therapeutics targeting GPCRs with higher specificity and efficacy. Relevant publications: Zhong X, Li Q, Polacco BJ, Patil T, Marley A, Foussard H, Khare P, Vartak R, Xu J, DiBerto JF, Roth BL, Eckhardt M, von
-
. This is a two-year position that is targeted at applicants who are preparing for an academic career at a leading research university. The Fellow is expected to start this position in Fall 2025
-
will primarily rely on perturbation assay via targeted treatments and manipulation of gene expression in cell culture, and patient-derived models. Required Qualifications: The ideal candidate should have
-
in PAH. Our work blends classical cell and molecular biology with cutting-edge genomics and proteomics, aiming to identify novel therapeutic targets for PAH. Required Qualifications: Ideal candidates
-
for Biomedical Informatics Research at Stanford University. This position emphasizes conducting real-world evidence studies using various causal inference methods (e.g., target trial emulation) to examine
-
types and diseases, as well as important gene/environmental interactions. The successful applicant will be immersed in cutting-edge high throughput gene targeting and single cell RNA-seq, and in
-
selectively targeted pharmacotherapy, rapid-acting therapeutics, and neuromodulation approaches, including guanfacine (ACE-D (link is external) ), pramipexole (SPARCLE (link is external) ), MDMA-assisted